Asenapine-Induced Acute Dystonia in an Adolescent Male

Dhrubajyoti Bhuyan, Soumitra Ghosh, Arnab Bhattacharya, Samir Kumar Praharaj

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Asenapine is a sublingually absorbed newer second-generation antipsychotic that is approved for the treatment of schizophrenia and bipolar disorder in patients, with a lower extrapyramidal adverse effect potential. We report an adolescent boy having schizophrenia who developed an acute dystonic reaction after 4 days when the dose of asenapine was increased from 10 to 15 mg per day.

Original languageEnglish
Pages (from-to)955-956
Number of pages2
JournalJournal of Child and Adolescent Psychopharmacology
Volume26
Issue number10
DOIs
Publication statusPublished - 01-12-2016

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this